Akero Therapeutics Inc (NASDAQ:AKRO)
| 37.81 Delayed Data As of 3:59pm ET |  -2.49 / -6.18%Today’s Change | 7.52 Today|||52-Week Range 54.88 | -31.00% Year-to-Date |
Latest AKRO News | Press Releases
No recent news for Akero Therapeutics Inc.
Today’s Trading
| Previous close | 40.30 |
| Today’s open | 39.67 |
| Day’s range | 36.09 - 40.08 |
| Volume | 49,089 |
| Average volume (3 months) | 716,611 |
| Market cap | $1.8B |
Data as of 3:59pm ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | +0.68% |
| Earnings growth (this year) | -12.78% |
| Earnings growth (next 5 years) | -14.08% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PCRXPacira Biosciences I... | -0.59 | -1.45% |
| ---- | ||
| GRFSGrifols SA | +0.28 | +3.96% |
| SUPNSupernus Pharmaceuti... | +0.17 | +0.47% |
Data as of 3:59pm ET, 03/30/2023
Financials
| Next reporting date | May 17, 2023 |
| EPS forecast (this quarter) | -$0.70 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$112.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
